These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening. Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012599. PubMed ID: 28295159 [TBL] [Abstract][Full Text] [Related]
9. Serum markers for Down's syndrome in relation to number of previous births and maternal age. Wald NJ; Watt HC Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278 [TBL] [Abstract][Full Text] [Related]
10. Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight. Wald NJ; Cuckle HS; Densem JW; Kennard A; Smith D Br J Obstet Gynaecol; 1992 Feb; 99(2):144-9. PubMed ID: 1372820 [TBL] [Abstract][Full Text] [Related]
11. The use of free beta-hCG in antenatal screening for Down's syndrome. Wald N; Densem J; Stone R; Cheng R Br J Obstet Gynaecol; 1993 Jun; 100(6):550-7. PubMed ID: 7687460 [TBL] [Abstract][Full Text] [Related]
12. Second-trimester maternal serum screening for Down's syndrome: free beta-human chorionic gonadotrophin (HCG) and alpha-fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha-fetoprotein and unconjugated oestriol. Extermann P; Bischof P; Marguerat P; Mermillod B Hum Reprod; 1998 Jan; 13(1):220-3. PubMed ID: 9512261 [TBL] [Abstract][Full Text] [Related]
15. Cross-trimester repeated measures testing for Down's syndrome screening: an assessment. Wright D; Bradbury I; Malone F; D'Alton M; Summers A; Huang T; Ball S; Baker A; Nix B; Aitken D; Crossley J; Cuckle H; Spencer K Health Technol Assess; 2010 Jul; 14(33):1-80. PubMed ID: 20624355 [TBL] [Abstract][Full Text] [Related]
16. Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. International Prenatal Screening Research Group. Wald NJ; George L; Smith D; Densem JW; Petterson K Br J Obstet Gynaecol; 1996 May; 103(5):407-12. PubMed ID: 8624312 [TBL] [Abstract][Full Text] [Related]
17. [Evaluation of Down's syndrome screening methods using maternal serum biochemistry in the second trimester pregnancy]. Yu DY; Fu P; Zhang ZH; Wang F; Han MY; Ren HY; Zhao W; Zhang K; Li S; Jiang N Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Jun; 28(3):332-5. PubMed ID: 21644235 [TBL] [Abstract][Full Text] [Related]
18. Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in pregnancies with insulin-dependent diabetes: implications for screening for Down's syndrome. Wald NJ; Cuckle HS; Densem JW; Stone RB Br J Obstet Gynaecol; 1992 Jan; 99(1):51-3. PubMed ID: 1372176 [TBL] [Abstract][Full Text] [Related]
19. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A. Haddow JE; Palomaki GE; Knight GJ; Foster DL; Neveux LM J Med Screen; 1998; 5(3):115-9. PubMed ID: 9795869 [TBL] [Abstract][Full Text] [Related]
20. Effect of allowing for ethnic group in prenatal screening for Down's syndrome. Watt HC; Wald NJ; Smith D; Kennard A; Densem J Prenat Diagn; 1996 Aug; 16(8):691-8. PubMed ID: 8878277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]